|
|
Post by peppy on Mar 10, 2023 11:31:41 GMT -5
MNKD volume at 20 mins of trade is high volume. MNKD would see 300,000 shares the first hour of trade, plenty of days, so high volume, down. 354,013 shares Avg. Volume 3,853,708 $4.4750-0.1450 (-3.14%) As of 09:50AM EST. Market open. $4.40 needs to hold. MNKD volume at 30 mins of trade, real time, 450,587 shares summary, 456,326 $4.5400. -0.0800 (-1.7316%) As of 10:01AM EST. Market open. MNKD volume at 1 hour of trade, real time, 589,512 shares summary, 600,723 $4.51. -0.11 (-2.3809%) volume has slowed. MNKD volumhattwo hours of trade, real time, 911,975 shares. summary, 912,150 $4.635. +0.015. (+0.32%) As of 11:30AM EST. Market open. |
|
|
|
Post by peppy on Mar 10, 2023 10:15:21 GMT -5
My comment on a possible 3 handle is just realistic view of the overall market. The chartists are saying 4.40 is hard support, but I have my reservations. Too many times I get hope from chartists saying saying 6 then up to 12 and it doesn’t happen. I’m not blaming anyone but myself, reading the charts is only one input. But if anyone thinks MNKD can’t break support and slip back into the 3, I think they should hard. If I had sold covered calls when the stock was above 5, I would fell more comfortable right now.Soulda, woulda, coulda. |
|
|
|
Post by peppy on Mar 10, 2023 10:04:52 GMT -5
Millions of shares traded after hours. Down big during trading hours. This is complete and utter bull shit. Take any big cap stock. If half of its volume occurred after hours and didn't effect the price it would be considered a total sham. Back to penny land. Nice weekly scripts. Yeah, MNKD is being taken up. |
|
|
|
Post by peppy on Mar 10, 2023 9:51:57 GMT -5
MNKD volume at 20 mins of trade is high volume. MNKD would see 300,000 shares the first hour of trade, plenty of days, so high volume, down.
354,013 shares
Avg. Volume 3,853,708
$4.4750-0.1450 (-3.14%)
As of 09:50AM EST. Market open.
$4.40 needs to hold.
MNKD volume at 30 mins of trade,
real time, 450,587 shares
summary, 456,326
$4.5400. -0.0800 (-1.7316%)
As of 10:01AM EST. Market open.
MNKD volume at 1 hour of trade,
real time, 589,512 shares
summary, 600,723
$4.51. -0.11 (-2.3809%)
volume has slowed.
|
|
|
|
Post by peppy on Mar 10, 2023 4:31:54 GMT -5
work? The V-Go provides a continuous preset basal rate of insulin and allows for on-demand bolus dosing around mealtimes thereby providing an alternative to taking multiple daily insulin injections. The V-Go insulin delivery system: Simplifies basal-bolus insulin therapy with its easy-to-use delivery system. How does this not compete with Afrezza?Afrezza is a meal time fast acting insulin. Afrezza users still use basal insulin. Rapid acting subq insulin users also use basal insulin. The Kreb's cycle. In the presence of oxygen one glucose makes 33 ATP. the Krebs cycle and electron transport chain occur inside the mitochondria. Electron carriers such as NADH produced during glycolysis and the Krebs cycle pass their electrons to the electron transport chain, which results in synthesis of a lot of ATP. We breathe and our hearts pump 24/7/365. |
|
|
|
Post by peppy on Mar 9, 2023 17:31:19 GMT -5
$4.40 has not hit. The 100 week is $4.20 and the 50 week is $4.12. $4.50 and $4.00 are hard support. schrts.co/BUWrCpJn |
|
|
|
Post by peppy on Mar 9, 2023 16:38:09 GMT -5
|
|
|
|
Post by peppy on Mar 9, 2023 16:16:23 GMT -5
MNKD volume at low all day, however it picked up the last hour of trade. MNKD Nasdaq real time volume, 2,752,860 shares. Just changed to 4,584,979 shares. Now 5,147,920 MNKD Nasdaq summary volume, 3,314,365 Avg. Volume 3,821,645 $4.6200. -0.1600. (-3.35%) MNKD share price took out the feb 27 swing low of $4.61. schrts.co/DERBTExFNasdaq 11,338.35 -237.65(-2.05%) $SPX 3,918.32 -73.69 $INDU 32,254.86 -543.54(-1.66%) The dow, the measured move is 2,100 point, I'll post later it looks like another 1000 points to go. I went to the highs and lows list today. 70 new highs and 262 new lows at the time. Plenty of banking stocks on the new lows list. The news today, Silvergate announces liquidation www.cnbc.com/2023/03/09/bitcoin-ether-fall-after-go-to-crypto-bank-silvergate-announces-liquidation.htmlBanks having a difficult time with the inverted interest rates also. |
|
|
|
Post by peppy on Mar 8, 2023 16:09:59 GMT -5
MNKD Nasdaq real time volume, 1,683,371 shares. MNKD Nasdaq summary volume, 1,650,822 Avg. Volume 3,868,569 $4.78. +0.03 (+0.63%) side note, look at UTHR Monthly 6 trading days into the month. schrts.co/dAMUICQUMNKD daily, schrts.co/dAMUICQUMNKD weekly schrts.co/EffNGgSWMNKD Monthly schrts.co/VMmdQemq |
|
|
|
Post by peppy on Mar 7, 2023 23:31:17 GMT -5
@sayhey It still would not surprise me regarding non diabetics getting small bowel obstructions. Again, delayed gastric emptying was a known mechanism. I’d be semi surprised if SBOs didn’t happen for some. Obese people don’t often have the healthiest of diets. If you slow the transit of low fiber/highly processed food, I’d be shocked if the mud didn’t get stuck. On that note, I’ve had a dozen or so obese patients come in with IBS just in the past couple weeks. They are already having all the symptoms listed on the side effect list of GLP-1s/GIPs. For many/most, it’s a normal day. What are the possible side effects of OZEMPIC®? OZEMPIC® may cause serious side effects, including: • See “What is the most important information I should know about OZEMPIC®?” • inflammationofyourpancreas(pancreatitis).StopusingOZEMPIC®andcallyour healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back. • changes in vision. Tell your healthcare provider if you have changes in vision during treatment with OZEMPIC®. • low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use OZEMPIC® with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include: • dizziness or light-headedness • sweating • confusion or drowsiness • headache • blurred vision • slurred speech • shakiness • fast heartbeat • anxiety, irritability, or mood changes • hunger • weakness • feeling jittery • kidney problems (kidney failure). In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration) which may cause kidney problems to get worse. It is important for you to drink fluids to help reduce your chance of dehydration. • serious allergic reactions. Stop using OZEMPIC® and get medical help right away, if you have any symptoms of a serious allergic reaction including: • swelling of your face, lips, tongue or throat • problems breathing or swallowing • severe rash or itching • fainting or feeling dizzy • very rapid heartbeat • gallbladder problems. Gallbladder problems have happened in some people who take OZEMPIC®. Tell your healthcare provider right away if you get symptoms of gallbladder problems which may include: • pain in your upper stomach (abdomen) • yellowing of skin or eyes (jaundice) • fever • clay-colored stools The most common side effects of OZEMPIC® may include nausea, vomiting, diarrhea, stomach (abdominal) pain, and constipation. |
|
|
|
Post by peppy on Mar 7, 2023 23:07:57 GMT -5
The mechanism of blood glucose lowering also involves a minor delay in gastric emptying in the early postprandial phase. You say tomato I say tomato. Nausea Vomiting Diarrhea Abdominal pain Constipation www.novo-pi.com/ozempic.pdfAnd yet Ozempic is the 6th largest seller by revenue in the US. You could ask Ginger Vieira who uses it if it's worthwhile. aged, why would Ginger Vieira be using Ozempic? Ginger is a type one diabetic beyondtype1.org/getting-inhaled-insulin/Is Ginger doing the Sayhey study? I went to a website, Ginger uses metformin? Aged, do you think Ginger is on to something? Are you going to jump on the band wagon? Load em? |
|
|
|
Post by peppy on Mar 7, 2023 13:28:45 GMT -5
Looks like UTHR and LQDA getting hit due to MRK. Another competitor in pulmonary Hypertension market. Please share the background on this. UTHR United Therapeutics Corporation 238.36 -9.66 -3.89% UPDATE 1-Merck's drug boosts exercise capacity in pulmonary hypertension patients finance.yahoo.com/news/1-mercks-drug-boosts-exercise-171123013.htmlMarch 6 (Reuters) - Merck & Co Inc said on Monday its experimental therapy, sotatercept, helped increase exercise capacity in patients with a deadly disease that causes high pressure in blood vessels of the heart and lungs in a late-stage study. Acceleron Receives FDA Breakthrough Therapy Designation for Sotatercept in Pulmonary Arterial Hypertension Sotatercept, which Merck gained through its $11.5 billion buyout of Acceleron Pharma, combined with background therapy helped extend the distance that patients with pulmonary arterial hypertension could walk in six minutes by 40.8 meters. Sotatercept granted first FDA Breakthrough Therapy designation in pulmonary arterial hypertension since the Agency established the designation in 2013 Sotatercept is an investigational agent designed to be a selective ligand trap for members of the TGF-beta superfamily to rebalance BMPR-II signaling, which is a key molecular driver of PAH. In preclinical studies of PAH, sotatercept reversed pulmonary vessel muscularization and improved indicators of right heart failure. Recent topline analysis of the PULSAR Phase 2 trial of sotatercept in patients with PAH revealed the trial met the primary as well as key and other secondary endpoints, with adverse events consistent with previously published data on sotatercept in other diseases. Sotatercept, which is part of a licensing agreement with Bristol Myers Squibb, is also being evaluated in the SPECTRA Phase 2 trial in patients with PAH. For more information, please visit www.clinicaltrials.gov. On April 4, 2019, Celgene Corporation submitted for the Agency’s review an original Biologics License Application (BLA-761136) for REBLOZYL (luspatercept-aamt) for injection, for subcutaneous use. |
|
|
|
Post by peppy on Mar 7, 2023 10:51:14 GMT -5
I wonder how many PWDs are dying from intestinal blockage caused by GLP1s and there has not been a direct linkage between the cause of death and GLP1s? Of those 30k how many are GLP1 users? hmmmmm 30k is a really big number, if its 10k thats a huge number. Colostomy |
|
|
|
Post by peppy on Mar 7, 2023 10:25:32 GMT -5
The mechanism of blood glucose lowering also involves a minor delay in gastric emptying in the early postprandial phase. You say tomato I say tomato. Nausea Vomiting Diarrhea Abdominal pain Constipation www.novo-pi.com/ozempic.pdfAnd yet Ozempic is the 6th largest seller by revenue in the US. You could ask Ginger Vieira who uses it if it's worthwhile. yes, Ozempic is big. Novo Nordisk |
|
|
|
Post by peppy on Mar 7, 2023 9:16:21 GMT -5
Scientists raise alarm over potentially deadly side effect from celeb-favorite fat-loss drug Wegovy and Ozempic that may have been MISSED in trials After observing over 500,000 reports, they found that people who used GLP-1 drugs for diabetes management were 4.5 times more likely to suffer intestine obstruction. Intestinal obstruction is responsible for around 30,000 deaths in the US every year. We knew it was a mess but it might be worse than I thought. Maybe this is why most stop using within 2 years as they develop bad intestinal issues. www.dailymail.co.uk/health/article-11826247/Scientists-raise-alarm-potentially-deadly-effect-fat-loss-shot-Wegovy.html The mechanism of blood glucose lowering also involves a minor delay in gastric emptying in the early postprandial phase. You say tomato I say tomato. Nausea Vomiting Diarrhea Abdominal pain Constipation www.novo-pi.com/ozempic.pdf |
|
